Google DeepMind just unveiled AlphaProtein Novo, an AI pipeline that builds functional enzymes from scratch without relying on natural templates. The system designs both 3D structures and amino acid sequences, proving itself in wet labs by synthesizing drug compounds and breaking down toxic plastics. The code is now open on GitHub.
Alphabet’s drug discovery arm Isomorphic Labs is gearing up to launch its first clinical trials in humans. Born out of DeepMind’s AlphaFold breakthroughs, the company is targeting cancer and immunology programs in London, aiming to dramatically improve the brutal 10% success rate typical of traditional drug trials.
Google DeepMind just released the software code for its protein-folding model AlphaFold 3 for non-commercial scientific research. The release follows six months of academic backlash over withholding the code, though accessing the actual model weights still requires an application request.
